Digital Turbine, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Digital Turbine, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2019 | $27.19M | Jun 3, 2019 |
| FY2018 | Dec 31, 2018 | $30.41M | Jun 3, 2019 |
| FY2018 | Sep 30, 2018 | $23.85M | Jun 3, 2019 |
| FY2018 | Jun 30, 2018 | $22.11M | Jun 3, 2019 |
| FY2018 | Mar 31, 2018 | $20.96M | Jun 3, 2019 |
| FY2018 | Dec 31, 2017 | $22.73M | Jun 3, 2019 |
| FY2018 | Sep 30, 2017 | $15.91M | Jun 3, 2019 |
| FY2018 | Jun 30, 2017 | $15.15M | Jun 3, 2019 |
| FY2017 | Mar 31, 2017 | $11.60M | Jun 12, 2018 |
| FY2017 | Dec 31, 2016 | $11.77M | Jun 12, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $490.51M | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | $544.48M | Jun 16, 2025 |
| FY2025 | Mar 31, 2023 | $665.92M | Jun 16, 2025 |
| FY2024 | Mar 31, 2022 | $747.60M | May 28, 2024 |
| FY2021 | Mar 31, 2021 | $95.08M | Jun 10, 2021 |
| FY2021 | Dec 31, 2020 | $88.59M | Jun 10, 2021 |
| FY2021 | Sep 30, 2020 | $70.89M | Jun 10, 2021 |
| FY2021 | Jun 30, 2020 | $59.01M | Jun 10, 2021 |
| FY2021 | Mar 31, 2020 | $39.35M | Jun 10, 2021 |
| FY2021 | Dec 31, 2019 | $36.02M | Jun 10, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $255.22M | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | $282.26M | Jun 16, 2025 |
| FY2025 | Mar 31, 2023 | $356.67M | Jun 16, 2025 |
| FY2024 | Mar 31, 2022 | $376.95M | May 28, 2024 |
| FY2023 | Mar 31, 2021 | $134.93M | May 25, 2023 |
| FY2019 | Mar 31, 2020 | $15.33M | Jun 2, 2020 |
| FY2019 | Dec 31, 2019 | $14.04M | Jun 2, 2020 |
| FY2019 | Sep 30, 2019 | $12.31M | Jun 2, 2020 |
| FY2019 | Jun 30, 2019 | $12.00M | Jun 2, 2020 |
| FY2019 | Mar 31, 2019 | $10.95M | Jun 2, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($92.10M) | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | ($420.23M) | Jun 16, 2025 |
| FY2025 | Mar 31, 2023 | $16.67M | Jun 16, 2025 |
| FY2024 | Mar 31, 2022 | $35.55M | May 28, 2024 |
| FY2023 | Mar 31, 2021 | $54.88M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $13.90M | Jun 6, 2022 |
| FY2021 | Mar 31, 2019 | ($6.01M) | Jun 10, 2021 |
| FY2019 | Mar 31, 2018 | ($52.86M) | Jun 2, 2020 |
| FY2018 | Mar 31, 2017 | ($24.26M) | Jun 3, 2019 |
| FY2017 | Mar 31, 2016 | ($28.03M) | Jun 12, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($54.08M) | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | ($374.44M) | Jun 16, 2025 |
| FY2025 | Mar 31, 2023 | $46.17M | Jun 16, 2025 |
| FY2024 | Mar 31, 2022 | $92.24M | May 28, 2024 |
| FY2021 | Mar 31, 2021 | $15.95M | Jun 10, 2021 |
| FY2021 | Dec 31, 2020 | $20.52M | Jun 10, 2021 |
| FY2021 | Sep 30, 2020 | $12.12M | Jun 10, 2021 |
| FY2021 | Jun 30, 2020 | $10.62M | Jun 10, 2021 |
| FY2021 | Mar 31, 2020 | $2.93M | Jun 10, 2021 |
| FY2021 | Dec 31, 2019 | $4.13M | Jun 10, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $39.46M | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | $54.16M | Jun 16, 2025 |
| FY2025 | Mar 31, 2023 | $56.49M | Jun 16, 2025 |
| FY2024 | Mar 31, 2022 | $52.72M | May 28, 2024 |
| FY2023 | Mar 31, 2021 | $20.12M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $12.02M | Jun 6, 2022 |
| FY2021 | Mar 31, 2019 | $10.88M | Jun 10, 2021 |
| FY2019 | Mar 31, 2018 | $9.65M | Jun 2, 2020 |
| FY2018 | Mar 31, 2017 | $9.28M | Jun 3, 2019 |
| FY2017 | Mar 31, 2016 | $4.88M | Jun 12, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $11.88M | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | $28.68M | Jun 16, 2025 |
| FY2025 | Mar 31, 2023 | $113.38M | Jun 16, 2025 |
| FY2024 | Mar 31, 2022 | $84.74M | May 28, 2024 |
| FY2023 | Mar 31, 2021 | $62.80M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $31.38M | Jun 6, 2022 |
| FY2021 | Mar 31, 2019 | $1.27M | Jun 10, 2021 |
| FY2019 | Mar 31, 2018 | $6.97M | Jun 2, 2020 |
| FY2018 | Mar 31, 2017 | ($6.66M) | Jun 3, 2019 |
| FY2017 | Mar 31, 2016 | ($7.07M) | Jun 12, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $812.85M | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | $865.54M | Jun 16, 2025 |
| FY2024 | Mar 31, 2023 | $1.27B | May 28, 2024 |
| FY2023 | Mar 31, 2022 | $1.46B | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $260.37M | Jun 6, 2022 |
| FY2021 | Mar 31, 2020 | $184.01M | Jun 10, 2021 |
| FY2019 | Mar 31, 2019 | $82.86M | Jun 2, 2020 |
| FY2018 | Mar 31, 2018 | $86.61M | Jun 3, 2019 |
| FY2017 | Mar 31, 2017 | $107.58M | Jun 12, 2018 |
| FY2016 | Mar 31, 2016 | $121.94M | Jun 14, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $658.90M | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | $651.61M | Jun 16, 2025 |
| FY2024 | Mar 31, 2023 | $659.30M | May 28, 2024 |
| FY2023 | Mar 31, 2022 | $942.29M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $115.26M | Jun 6, 2022 |
| FY2021 | Mar 31, 2020 | $106.56M | Jun 10, 2021 |
| FY2019 | Mar 31, 2019 | $46.50M | Jun 2, 2020 |
| FY2018 | Mar 31, 2018 | $58.94M | Jun 3, 2019 |
| FY2017 | Mar 31, 2017 | $45.54M | Jun 12, 2018 |
| FY2016 | Mar 31, 2016 | $39.67M | Jun 14, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $153.96M | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | $213.93M | Jun 16, 2025 |
| FY2024 | Mar 31, 2023 | $605.20M | May 28, 2024 |
| FY2023 | Mar 31, 2022 | $514.57M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $145.11M | Jun 6, 2022 |
| FY2021 | Mar 31, 2020 | $77.45M | Jun 10, 2021 |
| FY2021 | Mar 31, 2019 | $36.36M | Jun 10, 2021 |
| FY2021 | Mar 31, 2018 | $27.67M | Jun 10, 2021 |
| FY2019 | Mar 31, 2017 | $62.05M | Jun 2, 2020 |
| FY2018 | Mar 31, 2016 | $82.27M | Jun 3, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $221.74M | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | $220.07M | Jun 16, 2025 |
| FY2024 | Mar 31, 2023 | $561.58M | May 28, 2024 |
| FY2023 | Mar 31, 2022 | $559.79M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $80.18M | Jun 6, 2022 |
| FY2021 | Mar 31, 2020 | $69.26M | Jun 10, 2021 |
| FY2021 | Mar 31, 2019 | $42.27M | Jun 10, 2021 |
| FY2021 | Mar 31, 2018 | $42.27M | Jun 10, 2021 |
| FY2019 | Mar 31, 2017 | $42.27M | Jun 2, 2020 |
| FY2018 | Mar 31, 2016 | $42.27M | Jun 3, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($687.44M) | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | ($595.34M) | Jun 16, 2025 |
| FY2024 | Mar 31, 2023 | ($175.12M) | May 28, 2024 |
| FY2023 | Mar 31, 2022 | ($191.79M) | May 25, 2023 |
| FY2022 | Mar 31, 2021 | ($227.33M) | Jun 6, 2022 |
| FY2021 | Mar 31, 2020 | ($282.22M) | Jun 10, 2021 |
| FY2019 | Mar 31, 2019 | ($296.12M) | Jun 2, 2020 |
| FY2018 | Mar 31, 2018 | ($290.11M) | Jun 3, 2019 |
| FY2017 | Mar 31, 2017 | ($237.25M) | Jun 12, 2018 |
| FY2016 | Mar 31, 2016 | ($212.99M) | Jun 14, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $39.39M | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | $32.92M | Jun 16, 2025 |
| FY2025 | Mar 31, 2023 | $75.06M | Jun 16, 2025 |
| FY2023 | Mar 31, 2022 | $126.77M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $30.78M | Jun 6, 2022 |
| FY2021 | Mar 31, 2020 | $21.53M | Jun 10, 2021 |
| FY2019 | Mar 31, 2019 | $10.89M | Jun 2, 2020 |
| FY2018 | Mar 31, 2018 | $12.72M | Jun 3, 2019 |
| FY2017 | Mar 31, 2017 | $6.15M | Jun 12, 2018 |
| FY2017 | Mar 31, 2016 | $11.23M | Jun 12, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $408.69M | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | $383.49M | Jun 16, 2025 |
| FY2024 | Mar 31, 2023 | $410.52M | May 28, 2024 |
| FY2023 | Mar 31, 2022 | $533.29M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $14.56M | Jun 6, 2022 |
| FY2019 | Mar 31, 2020 | $20.00M | Jun 2, 2020 |
| FY2012 | Mar 31, 2013 | $1.25M | Jul 2, 2013 |
| FY2012 | Mar 31, 2012 | $3.08M | Jul 2, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | (4) | Jun 16, 2025 |
| FY2025 | Mar 31, 2023 | 0 | Jun 16, 2025 |
| FY2024 | Mar 31, 2022 | 0 | May 28, 2024 |
| FY2023 | Mar 31, 2021 | 0 | May 25, 2023 |
| FY2022 | Mar 31, 2020 | 0 | Jun 6, 2022 |
| FY2021 | Mar 31, 2019 | 0 | Jun 10, 2021 |
| FY2019 | Mar 31, 2018 | 0 | Jun 2, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | (4) | Jun 16, 2025 |
| FY2025 | Mar 31, 2023 | 0 | Jun 16, 2025 |
| FY2024 | Mar 31, 2022 | 0 | May 28, 2024 |
| FY2023 | Mar 31, 2021 | 0 | May 25, 2023 |
| FY2022 | Mar 31, 2020 | 0 | Jun 6, 2022 |
| FY2021 | Mar 31, 2019 | 0 | Jun 10, 2021 |
| FY2019 | Mar 31, 2018 | 0 | Jun 2, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 105.98M | Jun 16, 2025 |
| FY2025 | Mar 31, 2024 | 102.12M | Jun 16, 2025 |
| FY2024 | Mar 31, 2023 | 99.46M | May 28, 2024 |
| FY2023 | Mar 31, 2022 | 97.16M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | 89.95M | Jun 6, 2022 |
| FY2021 | Mar 31, 2020 | 87.31M | Jun 10, 2021 |
| FY2019 | Mar 31, 2019 | 81.62M | Jun 2, 2020 |
| FY2018 | Mar 31, 2018 | 76.11M | Jun 3, 2019 |
| FY2017 | Mar 31, 2017 | 66.59M | Jun 12, 2018 |
| FY2016 | Mar 31, 2016 | 66.28M | Jun 14, 2017 |